Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
Authors
Keywords
COVID-19, Spike protein, RNA-dependent-RNA-polymerase, Main and papain-like proteases, Angiotensin-converting enzyme 2, Repurposing and , de novo, strategies
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 137, Issue -, Pages 111232
Publisher
Elsevier BV
Online
2021-01-14
DOI
10.1016/j.biopha.2021.111232
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
- (2020) Calvin J Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
- (2020) Markus Hoffmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence
- (2020) Kapil Khambholja et al. Travel Medicine and Infectious Disease
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
- (2020) Hongjing Gu et al. SCIENCE
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
- (2018) Min-Han Lin et al. ANTIVIRAL RESEARCH
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
- (2017) Li Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase
- (2017) Jin-Moo Lee et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus
- (2017) Yaping Sun et al. Viruses-Basel
- Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
- (2016) Shuo Su et al. TRENDS IN MICROBIOLOGY
- The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
- (2015) Yahira M. Báez-Santos et al. ANTIVIRAL RESEARCH
- Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
- (2015) Kai-Wen Cheng et al. ANTIVIRAL RESEARCH
- Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity
- (2015) Hannah L. Peters et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chalcones isolated fromAngelica keiskeiinhibit cysteine proteases of SARS-CoV
- (2015) Ji-Young Park et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase
- (2015) Jin-Beom Cho et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- The RNA-dependent RNA polymerase of the influenza A virus
- (2014) Thomas M Stubbs et al. Future Virology
- X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases
- (2014) Yahira M. Báez-Santos et al. JOURNAL OF MEDICINAL CHEMISTRY
- Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa
- (2013) Jung Keun Cho et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase
- (2012) Adeyemi O. Adedeji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diarylheptanoids from Alnus japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
- (2012) Ji-Young Park et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
- (2012) Ji-Young Park et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
- (2012) M. Kawase et al. JOURNAL OF VIROLOGY
- 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)
- (2011) Mi Kyoung Kim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
- (2011) Kenichi Akaji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation
- (2010) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease
- (2009) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
- (2009) B. R. O'Keefe et al. JOURNAL OF VIROLOGY
- The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent
- (2009) Aartjan J. W. te Velthuis et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search